Association of CPI-17 with protein kinase C and casein kinase I

Biochem Biophys Res Commun. 2004 Mar 26;316(1):39-47. doi: 10.1016/j.bbrc.2004.02.014.

Abstract

The protein kinase C-potentiated inhibitor protein of 17kDa, called CPI-17, specifically inhibits myosin light chain phosphatase (MLCP). Phosphorylation of Thr-38 in vivo highly potentiates the ability of CPI-17 to inhibit MLCP. Thr-38 has been shown to be phosphorylated in vitro by a number of protein kinases including protein kinase C (PKC), Rho-associated coiled-coil kinase (ROCK), and protein kinase N (PKN). In this study we have focused on the association of protein kinases with CPI-17. Using affinity chromatography and Western blot analysis, we found interaction with all PKC isotypes and casein kinase I isoforms, CKIalpha and CKI. By contrast, ROCK and PKN did not associate with CPI-17, suggesting that PKC may be the relevant kinase that phosphorylates Thr-38 in vivo. CPI-17 interacted with the cysteine-rich domain of PKC and was phosphorylated by all PKC isotypes. We previously found that CPI-17 co-purified with casein kinase I in brain suggesting they are part of a complex and we now show that CPI-17 associates with the kinase domain of CKI isoforms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Brain / enzymology
  • Casein Kinases
  • Catalytic Domain
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Isoenzymes / metabolism
  • Muscle Proteins / metabolism*
  • Phosphoprotein Phosphatases
  • Phosphoproteins / metabolism*
  • Phosphorylation
  • Protein Kinase C / chemistry
  • Protein Kinase C / metabolism*
  • Protein Kinases / chemistry
  • Protein Kinases / metabolism*
  • Protein Structure, Tertiary

Substances

  • Intracellular Signaling Peptides and Proteins
  • Isoenzymes
  • Muscle Proteins
  • PPP1R14A protein, human
  • Phosphoproteins
  • Protein Kinases
  • protein kinase D
  • Casein Kinases
  • Protein Kinase C
  • Phosphoprotein Phosphatases